1. The authors need to be more consistent in their description of the main aim and primary outcome(s) of the study, and more clearly differentiate the primary outcome(s) from the secondary (i.e., intermediate outcomes). One key reason that this distinction is important is that the study is powered based on one primary outcome--child development score "at-risk"--and they might not have enough power to adequately assess impact on the other outcomes.
2. Related to comment (1), including "(p<0.05)" in the description of the intermediate outcomes is problematic because the study was not powered to detect impact on these additional outcomes. As a result, a p-value greater than 0.05 for these outcomes should not necessarily be interpreted as evidence of no impact, and might rather be a false negative due to insufficient power. The CHA outcomes are particularly problematic from a power perspective, as there will only be 24 CHAs in the study.
3. Furthermore, if the authors plan to test impact on all eight outcomes, they should consider the risk of false positives and possibly use a Bonferroni correction, i.e., a lower significance threshold. The "8. Data Analysis" section suggests that the impact analysis will only be conducted on the three child development and nutrition outcomes, but again the protocol mentions in several places an aim of testing impact on the intermediate outcomes.
4. With respect to the power calculation, the authors need to consider the "design effect" that will result from clustered sampling. Intra-cluster correlation in the primary outcome could be significant, which will reduce the power of the study. In addition, the authors should justify the assumed impact on "at-risk" development scores. 5. Also related to the power calculation, it is not clear why the "atrisk" dichotomization is being used as the primary outcome rather than the continuous development score. The continuous score would provide greater statistical power. The "at-risk" dichotomization may also be seen as somewhat arbitrary. The "Specific Objectives" section seems to refer to a continuous score as the primary outcome; this should be fixed for consistency. 6. For the randomization, the authors should consider a covariateconstrained method rather than matched-pairing for greater statistical power given the small number of clusters. See: https://trialsjournal.biomedcentral.com/articles/10. 1186/1745-6215-13-120. 7 . The suggestion that "the study will add clusters until the desired sample size is reached" is confusing. Due to the "design effect" issue mentioned above, the number of clusters added affects statistical power in a way that targeting 698 children will yield different power depending on the number of clusters. Do the authors have an expected number of eligible children per cluster and do they expect the plan of including 12 clusters to be insufficient? 8. For the analysis, the authors should consider using an analysis of covariance (ANCOVA) approach rather than difference-indifferences. See: https://www.bmj.com/content/323/7321/1123. They should also indicate in their protocol what baseline covariates they plan to adjust for in the analysis, if any. Minor 9. "ICT" is used in the abstract but is not defined there. 10. The authors should mention how the primary outcome will be measured in the abstract. 11. The authors describe a cluster-randomized controlled trial and should include the term "cluster" in the title. 12. Cluster-randomized trials are experimental; it is not clear why the term "quasi-experimental" is used. The difference-in-differences analysis method when applied to observational data is quasiexperimental, but the approach described in the protocol is most appropriately categorized as experimental.
REVIEWER
Madeleine Ballard Community Health Impact Coalition, Germany REVIEW RETURNED 15-Feb-2019
GENERAL COMMENTS
The authors are to be commended for a clear, thoughtfullypresented protocol. Nevertheless, a few issues ought to be addressed prior to publication:
1. The theory of change could be improved to better draw out the expected role of the tablet. It might be helpful to, e.g., illustrate the ToC for the current program (w/o CHEST) and then present a second ToC, with a clear delineation of how CHEST is hypothesised to help accelerate/improve outcomes. (i.e. by drawing out CHEST components, e.g., "multiple choice data entry allows home visits to go quicker --> more visits", "videos make medical issues more vivid--> improved understanding" etc.). As it stands, the entity being examined in this study (CHEST) is a bit of a black box...the more its components can be delineated, the more potentially generalizable (& useful!) the results will be.
2. "Studies have shown that a digital health tool could help CHA (sic) overcome the difficulties that arise during a home visit"please characterise the types of studies (e.g. RCTs, quasiexperimental etc.) and cite 3. Please explain why distance to the department capitol is a relevant consideration for propensity matching (e.g. is this where the nearest primary/secondary/tertiary care is located?). Similarly, please explain the decision to exclude communities located more than 6 hours from Iquitos.
4.
What is the sample size and how many clusters will be used? On p. 6 the study population is said to include "200-400 children" from 12 communities; on p. 7 the sample size is listed as "698 children" and it says clusters (earlier defined as a community) will be added until the desired sample is reached...
5.
If CREDI having been validated in other low-resource settings is enough to justify its use, then why--when, as the authors note on p 4, studies have already indicated digital health tools can overcome the difficulties faced by CHAs during home visits--ought we conduct another RCT on a digital health tool? The authors reference "diverse contexts" but fail to tell us (a) how the setting in which they are testing CHEST is different than where tablet based applications have been tested before, (b) why that might affect its efficacy, and (c) why, given what we know already, a quasiexperimental cluster RCT is the best design to answer the relevant questions.
6. Under ethical considerations, are the authors able to add a sentence or two about perpetuation of the program (e.g. maintenance of the tablets etc.) if the intervention does work?
Typos: 1. Abstract "(ICT)" should be inserted next to the term information and communication technology prior to the acronym being used 2. p. 4 "mobile information and communication technology (ICT) can improve" should not be preceded by "a" 3. p. 4 What is meant by the phrase "enable local contexts"? How can contexts be enabled? I think a subject may be missing... 4. p. 4 "A study on the performance of CHA" should be "CHAs." Check that the plural form of the acronym is correct throughout. 5. p. 4 Should read "the impact such an intervention *could* have" 6. p. 5 "Objetivos" should read "Objectives" 7. p. 7 (Kelsey) (47) 8. p. 7 Define the abbreviation "ACS" before use REVIEWER Dr. Onaedo Ilozumba Researcher and Lecturer Vrije Universiteit Amsterdam Netherlands REVIEW RETURNED 16-Feb-2019
GENERAL COMMENTS
Overall, a well written protocol with minimal errors. Please find below some comments for strengthening the protocol.
1) The strength and limitations section should relate specifically to the methods.
2) The authors should pay attention to the consistent use of terminology, currently they use "good child development", "child development" and "cognitive development". There are also discussions interchangeably. As well using "ICT" in place of "mobile ICT".
3) The problem gap presented in the introduction requires some restructuring and additional evidence. Currently the authors provide 1) evidence on CHAs for improving child cognitive development, anemia and chronic malnutrition. 2)digital health and CHAs. However, the link between digital health and improvement of the intended outcomes is missing. As is the actual evidence on the use of digital health by CHAs for the intended outcomes.
4) The aim/objective of the project needs to be consistently provided. It currently is presented in different formulations throughout the protocol.
In the abstract it is presented as "However, there is a knowledge gap in how ICTs can impact child development in diverse settings, and the degree to which the programs can provide sustainable quality health services at scale."
However, in the background the aim is presented as "Therefore, the present study aims to demonstrate the impact of a digital tool on CHA performance in the Peruvian Amazon and document the implementation process for replicability"
And again a new formulation in the objectives section "The objective of the study is to evaluate the impact of the digital health tool (tablet with application) on cognitive development and nutrition status of children aged 10 to 48 months compared to children who receive home visits from CHA without the digital tool."
5) The authors could give more thought to a more comprehensive theory of change. This would involve not simply considering inputs, activities and outputs but also the factors which could influence or interrupt the achievement of the desired outputs and outcomes. While, this is not a required change such reflections would add depth to the narrative section related to the theory of change and the overall approach to the intervention implementation and evaluation.
6) The authors should provide more justification for the inclusion and exclusion criteria for the study. While it is very likely that most of these are probably very appropriate for the context, this is not immediately apparent to all readers. For example why does the primary caregiver need to be older than 16?
7) The authors clearly present the evaluation plan for the intervention but the details of the intervention are unclear. Based on the included timeline by February 2019 the development of visiting agendas, material, videos and application should be completed. The manuscript should be updated with more detailed descriptions of the intervention to facilitate comprehension.
8) The dissemination plans discuss sharing a study brief with participants. How comprehensible will this be to target audience. Are there perhaps more appropriate methods of dissemination for the population?
VERSION One key reason that this distinction is important is that the study is powered based on one primary outcome--child development score "at-risk"--and they might not have enough power to adequately assess impact on the other outcomes.
I re-titled the sections to indicate primary and secondary outcomes and rewrote some of the outcomes to be more conscious and consistent with the data analysis strategy and sample size. I hope this addresses your concern. If you have any further advise on how to make the outcomes more consistent, I'm all ears.
I removed the significance measurements (0.05) to allow for the improvements in the secondary outcomes to be recognized without being fully powered. If there is a better way to present secondary outcomes, I have been unsuccessful at identifying it.
The secondary outcomes are presented as being compared to baseline measurements with descriptive statistics, to identify if there is a change or difference. We will not have the power to determine the change is due to the intervention with x% confidence. The Analysis section includes this information.
4. With respect to the power calculation, the authors need to consider the "design effect" that will result from clustered sampling. Intra-cluster correlation in the primary outcome could be significant, which will reduce the power of the study. In addition, the authors should justify the assumed impact on "at-risk" development scores.
The sample size was recalculated to take into account the design effect and intra-cluster correlation. I think you'll like it.
5. Also related to the power calculation, it is not clear why the "at-risk" dichotomization is being used as the primary outcome rather than the continuous development score. The continuous score would provide greater statistical power. The "at-risk" dichotomization may also be seen as somewhat arbitrary. The "Specific Objectives" section seems to refer to a continuous score as the primary outcome; this should be fixed for consistency.
Good point! The continuous development score is now being used.
6. For the randomization, the authors should consider a covariate-constrained method rather than matched-pairing for greater statistical power given the small number of clusters. See: https://trialsjournal.biomedcentral.com/articles/10.1186/1745-6215-13-120.
Upon review of the technique, I agree. I will use the method to allocate the clusters to the different groups. I updated the section, Study Design, to reflect the change. Thanks for the tip! 7. The suggestion that "the study will add clusters until the desired sample size is reached" is confusing. Due to the "design effect" issue mentioned above, the number of clusters added affects statistical power in a way that targeting 698 children will yield different power depending on the number of clusters. Do the authors have an expected number of eligible children per cluster and do they expect the plan of including 12 clusters to be insufficient?
This issue has been address with the change in the sample size analysis.
8. For the analysis, the authors should consider using an analysis of covariance (ANCOVA) approach rather than difference-in-differences. See: https://www.bmj.com/content/323/7321/1123. They should also indicate in their protocol what baseline covariates they plan to adjust for in the analysis, if any.
Upon review of the ANCOVA technique, I also agree it will be a better fit. I included the approach in the protocol. Again, I appreciate the recommendation. I am learning a lot from your review! Minor 9. "ICT" is used in the abstract but is not defined there.(CHECK) 10. The authors should mention how the primary outcome will be measured in the abstract. (CHECK) 11. The authors describe a cluster-randomized controlled trial and should include the term "cluster" in the title.(CHECK) 12. Cluster-randomized trials are experimental; it is not clear why the term "quasi-experimental" is used. The difference-in-differences analysis method when applied to observational data is quasiexperimental, but the approach described in the protocol is most appropriately categorized as experimental. (CHECK)
Thank you for the insightful review. I learned a great deal through following up on your comments. I also greatly appreciated reading about your work at BU and seeing that you too are interested in health systems and child development. I look forward to following your work. Please feel free to connect with me if you have any questions or advice on the project. I will be based at UNC beginning in August (phd in MCH), working on child nutrition and development, and implementation science, and would be thrilled to collaborate with you if the opportunity ever arises.
Christopher Westgard cmwestgard@gmail.com
Reviewer: 2 Reviewer Name: Madeleine Ballard Institution and Country: Community Health Impact Coalition, Germany Please state any competing interests or state 'None declared': None declared Please leave your comments for the authors below The authors are to be commended for a clear, thoughtfully-presented protocol. Nevertheless, a few issues ought to be addressed prior to publication:
Good point! I revamped the ToC to reflect your suggestions. The ToC now describes the change anticipated due to the different components of the App. The changes/improvements that are created by the app are in comparison to the status-quo, a CHA program that uses traditional reporting and education materials and methods. I noted that, "The theory of change displayed in Figure 1 is presented in contrast to traditional CHA programs that use paper based reporting and educational material."
2. "Studies have shown that a digital health tool could help CHA (sic) overcome the difficulties that arise during a home visit" -please characterise the types of studies (e.g. RCTs, quasi-experimental etc.) and cite The statement was meant to reiterate what was presented in the previous paragraph (evidence of the effectiveness of mhealth tools). I re-stated it as follows, "As described above, an mhealth tool could help the CHA overcome some of the difficulties they have in conducting an effective home visit" 3. Please explain why distance to the department capitol is a relevant consideration for propensity matching (e.g. is this where the nearest primary/secondary/tertiary care is located?). Similarly, please explain the decision to exclude communities located more than 6 hours from Iquitos.
I deleted the inclusion of distance to capitol as a variable to consider for propensity matching and added distance to nearest to health center (level I-2). I also explained why the distance is being considered as an exclusion criteria (budget restraints).
4.
What is the sample size and how many clusters will be used? On p. 6 the study population is said to include "200-400 children" from 12 communities; on p. 7 the sample size is listed as "698 children" and it says clusters (earlier defined as a community) will be added until the desired sample is reached... I redefined the sample size calculation to account for inter-cluster correlation. It is now hopefully much more clear and consistent.
5. If CREDI having been validated in other low-resource settings is enough to justify its use, then why--when, as the authors note on p 4, studies have already indicated digital health tools can overcome the difficulties faced by CHAs during home visits--ought we conduct another RCT on a digital health tool? The authors reference "diverse contexts" but fail to tell us (a) how the setting in which they are testing CHEST is different than where tablet based applications have been tested before, (b) why that might affect its efficacy, and (c) why, given what we know already, a quasi-experimental cluster RCT is the best design to answer the relevant questions.
I further described that there is a lack of evidence of impact of an mhealth tool used for heath promotion and education. Also, there is little evidence of the effectiveness of an mhealth intervention in Peru. The background section has been revised to reflect these changes. Additionally, the study is no longer described as a quasi-experimental CRCT. That was an inaccurate designation.
A statement was added to the section, Ethical Considerations.
Typos: 1. Abstract "(ICT)" should be inserted next to the term information and communication technology prior to the acronym being used (CHECK) 2. p. 4 "mobile information and communication technology (ICT) can improve" should not be preceded by "a" (CHECK) 3. p. 4 What is meant by the phrase "enable local contexts"? How can contexts be enabled? I think a subject may be missing... That's a good question.. I replaced the phrase with, "empower local actors", which is still ambiguous, but I hope the point transmits. The phrase "enable local contexts" I got from implementation science literature. I tried to use it here to ensure the protocol can sit within the field of implementation science. I hope for my work to align with that field of research. To be honest, the phase, enable local contexts, seems like a rebranding of an age old concept, local empowerment.
p. 4 "
A study on the performance of CHA" should be "CHAs." Check that the plural form of the acronym is correct throughout.
(CHECK) 5. p. 4 Should read "the impact such an intervention *could* have" (CHECK) 6. p. 5 "Objetivos" should read "Objectives" (CHECK) 7. p. 7 (Kelsey) (47) (CHECK) 8. p. 7 Define the abbreviation "ACS" before use (CHECK) Thank you Dr. Ballard for the review. I feel privileged to receive your feedback on my study design. Cheers to you and BMJ for putting in the time and effort to truly teach me through this process. I reviewed your work and am inspired. It seems we have very similar interests. I hope to continue to identify opportunities to improve CHA performance and program policies. I will be following your work closely in the process. If there is ever an opportunity to chat or collaborate one day, I will be honored. I will be joining the Phd program at UNC in August. Please leave your comments for the authors below Overall, a well written protocol with minimal errors. Please find below some comments for strengthening the protocol.
I updated the section to reflect the strengths and limitations of the methodology/protocol, instead of touching on aspects of the intervention and implementation plan.
2) The authors should pay attention to the consistent use of terminology, currently they use "good child development", "child development" and "cognitive development". There are also discussions interchangeably. As well using "ICT" in place of "mobile ICT". I revised to try to limit the terminology to "child development", however, I feel the need to refer to "good child development" and "poor child development" to describe the distinct outcomes of the indicator. Is that reasonable? I changed all occurrences of ICT to mobile ICT.
Good point! I have not found ANY research that shows the impact of mobile ICT interventions on child development. The current study should will aim to fill that knowledge gap. I will update that information in the Background section. Do you know of any impact evaluations on ICTs for child development?
I updated the justification and objectives of the study throughout the paper. It should be more consistent throughout. I believe I addressed the examples you mentioned and throughout.
I am divided on two options to present the theory of change model. I was suggested by another reviewer to focus the ToC on the components of the App to unfold their expected contribution to the expected impact. Your suggestion represents the other option; to present the ToC of the intervention and implementation strategy, including potential barriers, etc. I feel that there would be too much overlap to present both styles. I have chosen to present the former, to focus on the components of the App/intervention. I hope you will agree that this will be most beneficial. If you believe that the ToC should focus on the implementation strategy I will make that change.
I further explained the justification for each inclusion and exclusion criteria for the study.
I hope the intervention is further clarified with the ToC that describes the various components of the App, as this is the essence of the intervention. I also further elaborated the details of the intervention in the section, Phase 4, Implementation of the Intervention.
The chronogram has been updated to reflect the delays we have incurred since initial submission of the study protocol. We are still finalizing material and developing the App.
This is a great question. I honestly do not know an effective method to share the findings of the study with the target population. They will feel the impact of the intervention better than I could ever try to present it to them. However, the research team will present the finds of the study to the CHAs and the caregivers, verbally, with the guidance of a written handout. The dissemination will have to occur during individual home visits or a community event. If the study is effective, the dissemination activity could encourage more caregivers to receive the intervention or further dedicate their efforts to the goals of CHA program. The Dissemination section was further elaborated to mention that the brief will be written and described in a manner that is intelligible for the target population.
Thank you Dr. Ilozumba for your review. It is a privilege to receive your suggestions. The revision process of the protocol has been extremely helpful and educational. I was excited to see that you were a reviewer, as I remember reading your paper, "I am not telling, the mobile is telling". That paper was one of key papers that have helped me design the intervention and study. Thank you! I also read several of your other works and found them very helpful, especially in this field of mhealth in LMIC. I will continue to follow your work through researchgate. If you have any further questions of comments regarding the protocol or the intervention, please do not hesitate to write me. I would love to hear from you.
VERSION 2 -REVIEW

REVIEWER
Peter Rockers
Boston University School of Public Health REVIEW RETURNED 29-May-2019
GENERAL COMMENTS
The authors have adequately addressed my comments.
REVIEWER
Madeleine Ballard
Icahn School of Medicine at Mt Sinai, USA REVIEW RETURNED 04-Jun-2019
GENERAL COMMENTS
Thank you to the author for the extensive edits. A few more items of concern before publication:
1. In line w/earlier comments, please add the word "Protocol" to the title.
2. Please copy edit the text you have added in response to the reviewers' comments. There are typos & awkward phrasing throughout. (e.g. The first bullet point of the strengths & limitations section could be significantly streamlined to read "The intermediate variables assessed will help refine the theory of change and clarify the process(es) that lead to behavior change", the final sentence "Although the instrument has been shown to have high correlation to directly observed survey, there is more potential for parent created biased" is nearly unintelligible.)
3. It remains unclear what comparing the means and frequency of the secondary outcomes would illuminate or how this approach
